Casdozokitug is an IgG1kappa monoclonal antibody that selectively binds to interleukin-27 (IL-27) and functions as a first-in-class human anti-IL-27 research compound designed to inhibit the immunosuppressive activity of this cytokine. Casdozokitug demonstrates particular relevance in tumor types where IL-27 contributes to the establishment of an immunosuppressive tumor microenvironment and resistance to immune checkpoint inhibitor therapies, thereby offering a novel immunology research tool.
Reinheit:
97.20%
CAS Nummer:
[2643331-37-5]
Target-Kategorie:
Interleukin|||IL Receptor
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
